Dr. Christos Hatzigeorgiou, DO

Dr. Hatzigeorgiou practices at Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System.

Dr. Hatzigeorgiou's NPI, 1831189752, was assigned on October 21, 2005. Dr. Hatzigeorgiou graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 1994. Dr. Hatzigeorgiou holds Georgia license 73144.

Dr. Hatzigeorgiou's primary practice is Wellstar MCG Health Medical Center, at 1120 15th Street, Augusta, GA 30912 in Richmond County. The practice phone is (706) 721-6569.

Dr. Hatzigeorgiou's primary practice is Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Hatzigeorgiou to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hatzigeorgiou practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Hatzigeorgiou's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Hatzigeorgiou's licenses on file in 2 states: Georgia and Missouri.

CMS data shows 332 Medicare services from Dr. Hatzigeorgiou across 4 procedure codes in 2024, for 114 Medicare patients. Medicare paid $13,512 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Hatzigeorgiou in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hatzigeorgiou's median patient age at 70, with 54% women.

In 2024, Dr. Hatzigeorgiou wrote 614 Medicare Part D claims for 87 patients. 84% of them were for generic drugs. CMS names the drug for 280 of them, across 15 drugs with 11 or more claims each, at $3,014 in total drug cost. In 2023, CMS named 265 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Hatzigeorgiou for performance year 2024, reported through an alternative payment model (APM). Dr. Hatzigeorgiou accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Hatzigeorgiou, published from 2011 to 2021. 2017 was the busiest year, with 2. The most frequent topics are Antihypertensive Agents, Colorectal Neoplasms and Diabetes Mellitus, Type 2. Dr. Hatzigeorgiou has published most often in J Environ Health Sci. Dr. Hatzigeorgiou's most frequent co-authors are Gadiel Rafael Alvarado, DO, Anthony Paul Basel, DO and Thaddeus Y. Carson, MD.

CMS Open Payments shows 8 general payments to Dr. Hatzigeorgiou from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $128.

Dr. Hatzigeorgiou graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 1994.